CANCELLED An Evening Lecture with Dr Peter Milner - Advances in the treatment of inherited and acquired fatal neurodegenerative dieases
5:30pm - 6:30pm /
Friday 13th March 2020
Type: Lecture /
Category: Public
- Caroline Mitchell
- Admission: Free
- Book now
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Join University of Liverpool graduate and Cardiologist, Dr Peter Milner for a unique insight into neurodegenerative disease research.
In this special lecture, Dr Milner will share the extraordinary results of clinical trials from a range of neurodegenerative diseases undertaken in Retrotope Inc., an emerging, clinical stage degenerative disease therapeutic company.
California-based Dr Milner is a cardiologist and successful entrepreneur with extensive experience in drug development, clinical trial design leading to approval in the fields of neuroscience, gastroenterology, cardiovascular, autoimmunity and immunology. He is co-inventor on almost 67 issued patents, an author of 33 original scientific articles and a Fellow of The American College of Cardiology.
There will be a drinks reception after the lecture.
In this special lecture, Dr Milner will share the extraordinary results of clinical trials from a range of neurodegenerative diseases undertaken in Retrotope Inc., an emerging, clinical stage degenerative disease therapeutic company.
California-based Dr Milner is a cardiologist and successful entrepreneur with extensive experience in drug development, clinical trial design leading to approval in the fields of neuroscience, gastroenterology, cardiovascular, autoimmunity and immunology. He is co-inventor on almost 67 issued patents, an author of 33 original scientific articles and a Fellow of The American College of Cardiology.
There will be a drinks reception after the lecture.